Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CGC
CGC logo

CGC Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
1.125
Open
1.120
VWAP
1.10
Vol
1.43M
Mkt Cap
479.66M
Low
1.090
Amount
1.58M
EV/EBITDA(TTM)
221.30
Total Shares
448.28M
EV
572.06M
EV/OCF(TTM)
--
P/S(TTM)
1.29
Canopy Growth Corporation is a cannabis company, which produces, distributes, and sells a diverse range of cannabis and cannabis-related products for both adult-use and medical purposes. The Company brands include tweed, DOJA, LivRelief Infused, Deep Space, Ace Valley, 7ACRES, Vert, Twd, Wana, Hiway and Canopy Medical. The LivRelief Infused is transdermal creams contain a delivery system designed to penetrate a range of cannabidiol (CBD) and tetrahydrocannabinol (THC). The Deep Space offers beverages and gummies, containing the THC potency available in the Canadian market. The Ace Valley is a cannabis brand focused on ready-to-enjoy beverages. The 7ACRES offers products that are crafted by cannabis enthusiasts. The Wana gummies are created with a handcrafted recipe made with pectin, not gelatin, creating a gluten-free shelf-stable recipe that doesn’t melt. Its Canopy Medical is a pharmaceutical manufacturer for the production, import and release of medical cannabis products in Germany.
Show More

Events Timeline

(ET)
2026-05-29
07:20:00
Canopy Growth Relaunches Tweed Brand in Germany
select
2026-05-07 (ET)
2026-05-07
08:00:00
Canopy Growth Expands Minor Cannabinoid Softgel Lineup
select
2026-04-23 (ET)
2026-04-23
13:10:00
Roth Capital: Cannabis Products Rescheduled to Schedule 3
select
2026-04-23
10:30:00
Trump Orders Medical Marijuana Products to Schedule III
select
2026-04-23
10:00:00
Trump Signs Order to Reschedule Medical Marijuana to Schedule III
select
link
2026-04-22 (ET)
2026-04-22
12:00:00
Trump Administration Expected to Reclassify Cannabis on Wednesday
select
link
2026-04-10 (ET)
2026-04-10
08:50:00
Significant Increases in Borrow Rates Among Liquid Option Names
select
2026-04-08 (ET)
2026-04-08
08:50:00
Significant Increases in Indicative Borrow Rates for Liquid Options
select
2026-03-31 (ET)
2026-03-31
07:40:00
Canopy Growth Launches New Cannabis Brand Deelish
select

News

Newsfilter
8.5
11:43 AMNewsfilter
PinnedCanopy Growth Relaunches Tweed Brand in German Medical Cannabis Market
  • Brand Relaunch: Canopy Growth has relaunched its Tweed brand in the German market, introducing three new cannabis strains, marking its first international product release and aiming to enhance its share in Germany's rapidly growing medical cannabis market.
  • Market Potential: The German medical cannabis market is projected to approach $1 billion in annual value by 2025, and through this brand relaunch, Canopy Growth seeks to leverage its brand equity to meet the rising demand effectively.
  • Product Expansion Plans: The initial launch includes three strains: Pablo's Revenge, Dante'z Inferno, and Frost'd Flakes, with plans to introduce up to five additional strains by June 2026, further diversifying its product portfolio to attract more customers.
  • Management Cease Trade Order: The company received a management cease trade order from the Ontario Securities Commission effective May 28, 2026, due to accounting technical errors requiring the refiling of financial statements, which may impact investor confidence and exert short-term pressure on stock prices.
Fool
9.5
05-23Fool
Canopy Growth Faces Earnings Restatement Concerns
  • Earnings Restatement Announcement: Canopy Growth has announced it will restate its financial results for the past two years, raising investor concerns about internal controls, especially as the company continues to lose money and its stock trades at $1.04, potentially undermining investor confidence.
  • Intensified Market Competition: The marijuana industry is highly competitive, with Canopy Growth facing pressure from both legal and illegal markets; despite ongoing legalization, the company has yet to achieve sustainable profitability, reflecting weak financial performance across the sector.
  • Technical Accounting Error: During the fiscal year-end reporting for 2026, the company identified a technical non-cash accounting error, determining that certain share-settled warrants should be classified as liabilities rather than equity, although this adjustment is not expected to impact key financial metrics like revenue or cash flows.
  • Cautious Investor Sentiment: While the restatement is not expected to affect the company's financial trajectory, investors should pay attention to the earnings report on June 15 and consider waiting until the restatement is complete before investing, as the risk/reward profile remains unfavorable until the company achieves sustainable profitability.
NASDAQ.COM
9.5
05-23NASDAQ.COM
Canopy Growth Earnings Restatement Raises Concerns
  • Earnings Restatement Impact: Canopy Growth's announcement to restate two years of financial results raises investor concerns about internal controls, although it is stated that key metrics like revenue and cash flows remain unaffected, potentially leading to stock price volatility.
  • Intense Market Competition: The marijuana sector is characterized by fierce competition, with Canopy Growth and peers like Tilray and Aurora Cannabis struggling to achieve sustainable profitability, indicating a complex and evolving market landscape that requires investor caution.
  • Stock Price Fluctuation: Following the restatement news, Canopy Growth's stock initially fell but later recovered, reflecting a shift in investor sentiment as the market digested the implications of the announcement and its technical nature.
  • Cautious Investment Advice: Given Canopy Growth's financial restatement and ongoing losses, investors are advised to wait until the restatement is complete before considering an investment, to avoid making decisions in a high-risk environment.
Yahoo Finance
9.5
05-23Yahoo Finance
Canopy Growth to Restate Two Years of Financials Ahead of Earnings
  • Financial Restatement Announcement: Canopy Growth has announced it will restate its financial results for the past two years due to a technical non-cash accounting error, which classified certain share-settled warrants as liabilities instead of equity, although this change is not expected to impact key financial metrics such as revenue, gross margin, or cash flows.
  • Stock Price Reaction: Following the announcement of the restatement, Canopy Growth's stock initially fell but later recovered, indicating that the market has understood the reasons behind the restatement, alleviating some investor concerns about the company's financial health.
  • Competitive Industry Pressure: The marijuana industry is highly competitive, with Canopy Growth facing price pressures from the illegal market; despite ongoing legalization, the company has yet to achieve sustainable profitability, reflecting the overall weak financial performance in the sector.
  • Cautious Investment Advice: Analysts recommend that investors should be cautious about investing in Canopy Growth until the restatement is complete, especially given that the company has not yet achieved profitability, suggesting that the risk/reward profile remains unfavorable.
NASDAQ.COM
9.5
05-21NASDAQ.COM
Canopy Growth Faces Ongoing Profitability Challenges
  • Ongoing Losses: Canopy Growth has faced years of net losses, with its latest quarterly report showing revenue of C$54.5 million and a net loss of nearly C$45.8 million, indicating persistent struggles with profitability that have severely impacted investor sentiment.
  • Dilutive Share Issuance: The company has repeatedly attempted to shore up its finances through dilutive secondary share issues, which have diluted existing shareholders' stakes and driven away potential investors, negatively affecting stock performance.
  • Acquisition of MTL Cannabis: Canopy Growth completed its acquisition of MTL Cannabis in March for C$125 million, and while MTL has posted some profits in the past four quarters, the deal is unlikely to significantly improve Canopy's financial situation, failing to fundamentally alter its financial struggles.
  • Market Environment Challenges: Regulatory bottlenecks in Canada and competition from gray and black markets continue to hinder market development, and despite the U.S. market's potential, legal uncertainties and fierce domestic competition pose significant challenges for Canopy Growth in achieving growth.
Fool
2.0
05-21Fool
Canopy Growth Stock Continues to Decline Amid Challenges
  • Stock Decline: Canopy Growth's stock has dropped over 12% since the beginning of May, contrasting with the nearly 2% gain of the S&P 500, indicating a pessimistic investor sentiment that could lead to further capital outflows.
  • Financial Struggles: The company's latest quarterly revenue was C$54.5 million, with a net loss nearing C$45.8 million; although the loss has narrowed, ongoing financial pressures raise doubts about future profitability, potentially leading to more dilutive share issues.
  • MTL Cannabis Acquisition: Canopy Growth completed its acquisition of MTL Cannabis in March for C$125 million (US$91 million), and while MTL has reported profits in the past four quarters, its revenue is unlikely to significantly improve Canopy's overall financial situation, failing to change the long-term loss trajectory.
  • Market Challenges: Regulatory bottlenecks in Canada and competition from the black market continue to hinder Canopy Growth's growth potential, while slow legal reforms in the U.S. present significant challenges in both markets, suggesting the need for further dilutive financing to sustain operations.
Wall Street analysts forecast CGC stock price to rise
4 Analyst Rating
Wall Street analysts forecast CGC stock price to rise
1 Buy
2 Hold
1 Sell
Hold
Current: 0.000
sliders
Low
1.03
Averages
2.52
High
5.90
Current: 0.000
sliders
Low
1.03
Averages
2.52
High
5.90
Canaccord
Buy
initiated
$2
AI Analysis
2026-03-27
Reason
Canaccord
Price Target
$2
AI Analysis
2026-03-27
initiated
Buy
Reason
Canaccord initiated coverage of Canopy Growth with a Buy rating and C$2 price target. Canopy is a leading cannabis company producing, distributing, and selling a "diverse range" of cannabis and cannabis-related products in key, global adult-use and medical cannabis markets, the analyst tells investors in a research note. The firm says the company's pivot from an asset-light, third-party supply model to an asset-right, in-house supply model will improve its global competitive positioning.
Alliance Global
Aaron Grey
Neutral
downgrade
2026-02-06
Reason
Alliance Global
Aaron Grey
Price Target
2026-02-06
downgrade
Neutral
Reason
Alliance Global analyst Aaron Grey lowered the firm's price target on Canopy Growth to C$1.80 from C$2.50 and keeps a Neutral rating on the shares following the fiscal Q3 report. The firm reduced the stock's multiple to reflect the potential impact from changes to veteran reimbursement and uncertainty around its gross margins.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CGC
Unlock Now

Valuation Metrics

The current forward P/E ratio for Canopy Growth Corp (CGC.O) is 20.37, compared to its 5-year average forward P/E of -3.80. For a more detailed relative valuation and DCF analysis to assess Canopy Growth Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-3.80
Current PE
20.37
Overvalued PE
9.95
Undervalued PE
-17.55

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-279.63
Current EV/EBITDA
-14.56
Overvalued EV/EBITDA
444.41
Undervalued EV/EBITDA
-1003.67

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
3.96
Current PS
1.31
Overvalued PS
7.88
Undervalued PS
0.03

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

how is cannibis securities doing today
Intellectia · 8 candidates
Market Cap: >= 100.00MPrice: >= $1.00Themes: The Cannabis IndustryMonthly Average Dollar Volume: >= 200,000
Ticker
Name
Market Cap$
top bottom
CGC logo
CGC
Canopy Growth Corp
511.04M
TLRY logo
TLRY
Tilray Brands Inc
803.02M
SNDL logo
SNDL
SNDL Inc
391.39M
VFF logo
VFF
Village Farms International Inc
328.97M
ACB logo
ACB
Aurora Cannabis Inc
201.89M
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.49B
list10 stocks up 5%
Intellectia · 371 candidates
Price Change Pct: >= $5.00
Ticker
Name
Market Cap$
top bottom
AGPU logo
AGPU
Axe Compute Inc
25.59M
ELPW logo
ELPW
eLong Power Holding Ltd
2.23M
TORO logo
TORO
Toro Corp
112.81M
NMAX logo
NMAX
Newsmax Inc
940.13M
BEEM logo
BEEM
Beam Global
32.13M
XNDU logo
XNDU
Xanadu Quantum Technologies Ltd
8.18B
Top stocks to buy between 1 and 2 dollors
Intellectia · 291 candidates
Region: USPrice: $1.00 - $2.00List Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
SID logo
SID
Companhia Siderurgica Nacional SA
1.78B
IQ logo
IQ
iQIYI Inc
1.35B
GERN logo
GERN
Geron Corp
1.08B
AMC logo
AMC
AMC Entertainment Holdings Inc
938.30M
OPK logo
OPK
OPKO Health Inc
918.47M
LXRX logo
LXRX
Lexicon Pharmaceuticals Inc
779.57M
what are the cheapest
Intellectia · 146 candidates
Price: $0.10 - $5.00Rsi Category: moderateRelative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20One Day Predict Return: >= 0.0%Monthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
QNCX logo
QNCX
Quince Therapeutics Inc
10.20M
GPUS logo
GPUS
Hyperscale Data Inc
54.64M
BURU logo
BURU
NUBURU Inc
29.16M
PMNT logo
PMNT
Perfect Moment Ltd
13.69M
OPTT logo
OPTT
Ocean Power Technologies Inc
83.41M
GUTS logo
GUTS
Fractyl Health Inc
73.79M
top 5 penny stocks?
Intellectia · 91 candidates
Market Cap: 50.00M - 2.00BRegion: USPrice: $0.10 - $5.00List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Month Price Change Pct: $0.00 - $150.00Monthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
RXT logo
RXT
Rackspace Technology Inc
409.23M
KOS logo
KOS
Kosmos Energy Ltd
1.03B
IOVA logo
IOVA
Iovance Biotherapeutics Inc
1.14B
GERN logo
GERN
Geron Corp
1.20B
TRX logo
TRX
TRX Gold Corp
516.12M
AQST logo
AQST
Aquestive Therapeutics Inc
481.91M
Should I Buy cannabis stocks?
Intellectia · 9 candidates
Market Cap: >= 50.00MThemes: The Cannabis IndustryList Exchange: XNYS, XNASMonthly Average Dollar Volume: >= 100,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
4.06B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.29B
CRON logo
CRON
Cronos Group Inc
1.01B
TLRY logo
TLRY
Tilray Brands Inc
874.97M
CGC logo
CGC
Canopy Growth Corp
440.50M
SNDL logo
SNDL
SNDL Inc
386.25M
cannabis
Intellectia · 8 candidates
Market Cap: >= 200.00MPrice: >= $1.00Themes: The Cannabis IndustryIs Optionable: TrueMonthly Average Dollar Volume: >= 200,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
4.06B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.29B
CRON logo
CRON
Cronos Group Inc
1.01B
TLRY logo
TLRY
Tilray Brands Inc
874.97M
CGC logo
CGC
Canopy Growth Corp
440.50M
SNDL logo
SNDL
SNDL Inc
386.25M
stocks under $2 for day trade today
Intellectia · 158 candidates
Price: <= $2.00Volume: >= 500,000Price Change Pct: $-5.00 - $20.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
PHIO logo
PHIO
Phio Pharmaceuticals Corp
12.06M
PLUG logo
PLUG
Plug Power Inc
2.84B
BURU logo
BURU
NUBURU Inc
56.42M
TIRX logo
TIRX
Tian Ruixiang Holdings Ltd
10.04M
JTAI logo
JTAI
Jet.AI Inc
5.61M
BTBT logo
BTBT
Bit Digital Inc
563.19M
marijuana stocks
Intellectia · 8 candidates
Market Cap: >= 200.00MRegion: US, CanadaPrice: >= $1.00Themes: The Cannabis IndustryList Exchange: XNYS, XNAS, XASEIs Optionable: TrueMonthly Average Dollar Volume: >= 300,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
3.70B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.41B
TLRY logo
TLRY
Tilray Brands Inc
1.01B
CRON logo
CRON
Cronos Group Inc
999.35M
CGC logo
CGC
Canopy Growth Corp
460.70M
SNDL logo
SNDL
SNDL Inc
406.85M
stocks to buy for 1.19 i only have $10
Intellectia · 105 candidates
Price: <= $1.19Weekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
ASST logo
ASST
Strive Inc
1.11B
UP logo
UP
Wheels Up Experience Inc
624.57M
CAN logo
CAN
Canaan Inc
498.64M
CGC logo
CGC
Canopy Growth Corp
460.70M
DVLT logo
DVLT
Datavault AI Inc
433.82M
BYND logo
BYND
Beyond Meat Inc
424.50M

Whales Holding CGC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Canopy Growth Corp (CGC) stock price today?

The current price of CGC is 1.0957 USD — it has decreased -2.14

What is Canopy Growth Corp (CGC)'s business?

Canopy Growth Corporation is a cannabis company, which produces, distributes, and sells a diverse range of cannabis and cannabis-related products for both adult-use and medical purposes. The Company brands include tweed, DOJA, LivRelief Infused, Deep Space, Ace Valley, 7ACRES, Vert, Twd, Wana, Hiway and Canopy Medical. The LivRelief Infused is transdermal creams contain a delivery system designed to penetrate a range of cannabidiol (CBD) and tetrahydrocannabinol (THC). The Deep Space offers beverages and gummies, containing the THC potency available in the Canadian market. The Ace Valley is a cannabis brand focused on ready-to-enjoy beverages. The 7ACRES offers products that are crafted by cannabis enthusiasts. The Wana gummies are created with a handcrafted recipe made with pectin, not gelatin, creating a gluten-free shelf-stable recipe that doesn’t melt. Its Canopy Medical is a pharmaceutical manufacturer for the production, import and release of medical cannabis products in Germany.

What is the price predicton of CGC Stock?

Wall Street analysts forecast CGC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CGC is2.52 USD with a low forecast of 1.03 USD and a high forecast of 5.90 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Canopy Growth Corp (CGC)'s revenue for the last quarter?

Canopy Growth Corp revenue for the last quarter amounts to 74.54M USD, decreased -0.29

What is Canopy Growth Corp (CGC)'s earnings per share (EPS) for the last quarter?

Canopy Growth Corp. EPS for the last quarter amounts to -0.18 USD, decreased -83.78

How many employees does Canopy Growth Corp (CGC). have?

Canopy Growth Corp (CGC) has 960 emplpoyees as of May 29 2026.

What is Canopy Growth Corp (CGC) market cap?

Today CGC has the market capitalization of 479.66M USD.